Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability

BACKGROUND: In breast cancer patients routine thromboprophylaxis is not recommended but individualized risk assessment is encouraged. The incorporation of hypercoagulability biomarkers could increase the sensitivity of risk assessment models (RAM) to identify patients at VTE risk. To this aim we inv...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Chaari, Mourad, Ayadi, Ines, Rousseau, Aurelie, Lefkou, Eleftheria, Van Dreden, Patrick, Sidibe, Fatoumata, Ketatni, Hela, Galea, Vassiliki, Khaterchi, Amir, Bouzguenda, Racem, Frikha, Mounir, Ghorbal, Lilia, Daoud, Jamel, Kallel, Choumous, Quinn, Martin, Gligorov, Joseph, Lotz, Jean Pierre, Hatmi, Mohamed, Elalamy, Ismail, Gerotziafas, Grigoris T
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4324665/
https://ncbi.nlm.nih.gov/pubmed/25535397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-991
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky